Target intelligence / Profile preview

Transmembrane protein 109 (TMEM109)

Target: TMEM109
Molecular classification: Ion channel (specifically voltage-gated monoatomic cation channel), Transmembrane protein

Overview

Transmembrane protein 109 (TMEM109) is a voltage-gated monoatomic cation channel, permeable to potassium and calcium ions, and primarily localizes to the endoplasmic reticulum membrane. TMEM109 has context-dependent roles in cellular stress responses: it facilitates apoptosis after genotoxic stress by amplifying p53 signaling in some cell types, while also exerting protective effects against ultraviolet C-induced cell death through recruitment of molecular chaperones such as αB-crystallin. This dual regulation underscores its functional complexity in balancing survival and death signals within the cell. TMEM109 is implicated in the cellular response to gamma radiation, DNA damage, and may have a role in cancer pathophysiology due to these functions. Despite its involvement in key stress response pathways, no drugs are currently approved specifically for modulating TMEM109 activity, and its utility as a therapeutic target remains primarily in experimental and mechanistic contexts.

Other names: Mitsugumin-23Mg23SND3hSND3MGC5508SRP-independent targeting 3 homologVoltage-gated monoatomic cation channel TMEM109

Mechanism of action

Increases apoptosis in response to genotoxic stress (via p53 amplification) Modulates cellular resistance and repair by recruiting protective chaperones such as αB-crystallin to the endoplasmic reticulum

Biological functions

Voltage-gated cation channel activity (transports monovalent and divalent cations such as potassium and calcium)Regulation of apoptotic signaling and cell deathCellular response to DNA damage, gamma radiation, and stressProtein-protein interactions (e.g., binding αB-crystallin for cytoprotective roles)Signal transduction within the endoplasmic reticulum

Disease associations

Cancer (roles in DNA damage signaling, p53 pathway, and apoptosis)Tissue damage response (including irradiation and UV damage)Potential association with neurological, cardiovascular, and other tissue pathologies based on animal phenotype studies

Safety considerations

No specific safety concerns have been reported for TMEM109 as a drug targetGiven its role in apoptosis and DNA damage signaling, off-target modulation could theoretically affect cell survival or tissue response to injury

Interacting drugs

No direct, clinically approved drugs are known to target TMEM109 specifically. It has been linked to expression changes in response to chemical/drug perturbation in various data sets, and it modulates apoptosis after exposure to drugs like etoposide (a DNA-damaging agent)

1 more in the full profile.

Biomarkers

Altered expression of TMEM109 has potential as a biomarker for cellular stress response and DNA damage signalingMay serve as a readout for efficacy of DNA-damaging anti-cancer therapies

Beyond the preview

Go deeper on Transmembrane protein 109 (TMEM109).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 109 (TMEM109).

Explore the full profile